Australia · Delayed Price · Currency is AUD Microba Life Sciences Company Description
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.
It operates through, Testing Services and Supplements, and Research and Development segments. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome.
In addition, it offers MetaPanel, a metagenomic test for pathogen detection; microba microbiome explorer; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel autoimmune diseases, oncology, and allergy.
Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
| Country | Australia |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Geoffrey Cockerill |
Contact Details
Address: 324 Queen Street Brisbane, QLD 4000 Australia | |
| Phone | 61 13 0097 4621 |
| Website | microba.com |
Stock Details
| Ticker Symbol | MAP |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000209868 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Dr. Luke Reid | Chief Executive Officer (Leave of Absence) |
| Prof. Gene Tyson | Co-Founder and Non-Executive Director |
| James Heath | Chief Financial Officer and Company Secretary |
| Prof. Philip Hugenholtz | Co-Founder and Chair of Scientific Advisory Board |
| Dr. David Wood | Chief Technology Officer |
| Prof. Lutz Krause | Chief Scientific Officer |
| Dr. Nicola Angel | Head of Laboratory Operations and Laboratory Director |
| Keith Byrne | Head of Test Operations |
| Eric Davies | Chief Revenue Officer |
| Alaster Stockwell-Jones | Managing Director of UK |